AKT1 and ovarian carcinoma: Similarly, the upregulation of miR-93, miR-223, or miR-216a expression can promote the cisplatin resistance of ovarian cancer through activation of the PI3K/AKT pathway caused by the sponging of PTEN (78, 81, 88, 89, 104).